Insect Stings Are Just a Buzzkill for Most Folks

TUESDAY, July 16, 2019 -- Although unwelcome, insect stings pose a serious risk threat to only a small percentage of people, a medical expert says.

"While millions of people suffer insect stings, true allergic reactions occur in a mere 0.4 to 0.8% of children and up to 3% of adults," said Dr. Morissa Ladinsky. She is an associate professor of pediatrics and adolescent medicine at the University of Alabama at Birmingham.

FDA Approves First Drug for Sinusitis With Nasal Polyps

THURSDAY, June 27, 2019 -- In what specialists say could be a turning point in care, the U.S. Food and Drug Administration on Wednesday approved the first drug to treat chronic sinusitis that involves the growth of polyps within the sinuses.

Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis -- defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said.

Should You Try Allergen Immunotherapy?

TUESDAY, July 9, 2019 -- If you're constantly sneezing and sniffling even though you take allergy medication to relieve symptoms, you may want to consider immunotherapy.

This treatment is aimed at desensitizing you to your allergy triggers, providing long-term relief from allergies and reducing the risk for asthma.

Immune-Targeted Treatment Might Help Prevent Peanut Allergy Crises

MONDAY, April 8, 2019 -- Allergic reactions to peanuts can be incredibly dangerous, causing the throat to close, the chest to tighten, and throw a person into life-threatening anaphylactic shock.

But researchers now believe they've found a way to head off that immune reaction by blocking the antibodies that cause it.